Baker Hughes CEO sells 272,593 shares under plan

Baker Hughes Co Chairman, President and CEO Lorenzo Simonelli exercised stock options and sold shares in a planned transaction.

Rhea-AI Filing Summary

Baker Hughes Co Chairman, President and CEO Lorenzo Simonelli exercised stock options and sold shares in a planned transaction. On March 4, 2026, he exercised 187,343 stock options, acquiring the same number of Class A common shares at an exercise price of $35.70 per share.

On the same date, he sold 272,593 Class A common shares at a weighted average price of $61.13 per share under a Rule 10b5-1 trading plan adopted on November 10, 2025. After these transactions, he directly owned 672,810 Class A common shares. The exercised stock options were originally granted on August 1, 2017 and vested in three equal annual installments beginning one year after grant.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Simonelli Lorenzo

Role Chairman, President and CEO

Sold 272,593 shs ($16.66M)

Approx. gross sale proceeds $16.66M

Approx. exercise cost $6.69M

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	187,343	$0.00	$0.00
Exercise	Class A Common Stock	187,343	$35.70	$6.69M
Sale	Class A Common Stock	272,593	$61.13	$16.66M

Holdings After Transaction: Stock Option (Right to Buy) — 187,344 contracts (Direct); Class A Common Stock — 672,810 shares (Direct)

Footnotes (3)

1. F1. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $62.28, inclusive. Details on the number of shares sold at each separate price will be provided to the Issuer, any shareholder of the Issuer, or staff of the Securities and Exchange Commission upon request.
3. F3. The stock option was granted on August 1, 2017 and vested in three equal annual installments beginning one year from the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Baker Hughes (BKR) CEO Lorenzo Simonelli report in this Form 4?

Lorenzo Simonelli reported exercising 187,343 stock options and selling 272,593 Baker Hughes Class A shares. The option exercise converted derivative securities into common stock, and the subsequent sale adjusted his direct holdings while remaining part of a pre-established 10b5-1 trading plan.

How many Baker Hughes (BKR) shares did the CEO sell and at what price?

He sold 272,593 Class A common shares at a weighted average price of $61.13. The shares were sold in multiple trades between $60.54 and $62.28, with detailed trade breakdowns available to the issuer, shareholders, or SEC staff upon request.

How many Baker Hughes (BKR) stock options did Lorenzo Simonelli exercise?

He exercised 187,343 stock options, acquiring the same number of Baker Hughes Class A common shares. The options carried an exercise price of $35.70 per share and were originally granted on August 1, 2017, vesting in three equal annual installments after grant.

Is the Baker Hughes (BKR) CEO’s share sale under a Rule 10b5-1 plan?

Yes. The reported sale of 272,593 Baker Hughes shares occurred under a Rule 10b5-1 trading plan. This plan was adopted by Lorenzo Simonelli on November 10, 2025, allowing pre-scheduled transactions independent of day-to-day market or company developments.

What is Lorenzo Simonelli’s Baker Hughes (BKR) share ownership after these transactions?

Following the March 4, 2026 transactions, Lorenzo Simonelli directly owned 672,810 Baker Hughes Class A common shares. This figure reflects both the conversion of 187,343 stock options into common stock and the open-market sale of 272,593 shares reported in the filing.

When were the exercised Baker Hughes (BKR) stock options originally granted and how did they vest?

The exercised stock options were granted on August 1, 2017 and vested in three equal annual installments. Vesting began one year after the grant date, meaning the award became fully vested over three years before being exercised in March 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 07:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simonelli Lorenzo

(Last) (First) (Middle)

575 NORTH DAIRY ASHFORD ROAD, SUITE 100

(Street)

HOUSTON TX 77079-1121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Baker Hughes Co [ BKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/04/2026		M(1)		187,343	A	$35.7	945,403	D
Class A Common Stock	03/04/2026		S(1)		272,593	D	$61.13(2)	672,810	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$35.7	03/04/2026		M(1)			187,343	(3)	08/01/2027	Class A Common Stock	187,343	$0	187,344	D

Explanation of Responses:

1. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $62.28, inclusive. Details on the number of shares sold at each separate price will be provided to the Issuer, any shareholder of the Issuer, or staff of the Securities and Exchange Commission upon request.

3. The stock option was granted on August 1, 2017 and vested in three equal annual installments beginning one year from the date of grant.

Remarks:

	/s/ Fernando Contreras, Attorney-in-fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.